title: Theta burst stimulation in the negative symptoms of schizophrenia and striatal dopamine release. An iTBS-[11C]raclopride PET case study.
authors.forename: Jerome
authors.initials: J
authors.lastname: Brunelin
authors.forename: David
authors.initials: D
authors.lastname: Szekely
authors.forename: Nicolas
authors.initials: N
authors.lastname: Costes
authors.forename: Marine
authors.initials: M
authors.lastname: Mondino
authors.forename: Thierry
authors.initials: T
authors.lastname: Bougerol
authors.forename: Mohamed
authors.initials: M
authors.lastname: Saoud
authors.forename: Marie-Françoise
authors.initials: MF
authors.lastname: Suaud-Chagny
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Poulet
authors.forename: Mircea
authors.initials: M
authors.lastname: Polosan
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000493:pharmacokinetics; D003342:Corpus Striatum / Q000000981:diagnostic imaging* / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods; D017397:Prefrontal Cortex / Q000502:physiology; D020891:Raclopride / Q000493:pharmacokinetics*; D012559:Schizophrenia / Q000000981:diagnostic imaging* / Q000473:pathology*; D050781:Transcranial Magnetic Stimulation / Q000379:methods
chemical_list: D014150:Antipsychotic Agents; D020891:Raclopride; D004298:Dopamine